SCHEMBL1713107

SCHEMBL1713107

Nc1nc(=O)c2c(ncn2Cc2ccccc2)[nH]1

nearest known ligand 0.61

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
PNP P00491 4/20 0.61
CNOT7 Q9UIV1 5/20 0.57
PARN O95453 1/20 0.57
SMN1; SMN2 Q16637 3/20 0.47
ALDH1A1 P00352 2/20 0.47
HPGD P15428 1/20 0.45
ADORA2B P29275 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
KMT2A Q03164 1/20 0.44
TYMS P04818 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988101 0.84 CNOT7 (0.55) PNPCNOT7PARNSMN1; SMN2ALDH1A1
SCHEMBL7974027 0.84 CNOT7 (0.57) PNPCNOT7PARNSMN1; SMN2ALDH1A1
SCHEMBL7975135 0.84 CNOT7 (0.52) PNPCNOT7PARNSMN1; SMN2ALDH1A1
Hydrochloric Acid SCHEMBL7987472 0.83 CNOT7 (0.54) PNPCNOT7PARNSMN1; SMN2ALDH1A1
Hydrochloric Acid SCHEMBL7985519 0.83 CNOT7 (0.51) PNPCNOT7PARNSMN1; SMN2ALDH1A1
SCHEMBL7975271 0.83 CNOT7 (0.56) PNPCNOT7PARNSMN1; SMN2ALDH1A1
SCHEMBL7985640 0.82 CNOT7 (0.53) PNPCNOT7PARNSMN1; SMN2ALDH1A1
SCHEMBL7975254 0.82 CNOT7 (0.55) PNPCNOT7PARNSMN1; SMN2ALDH1A1
Hydrochloric Acid SCHEMBL7987619 0.81 CNOT7 (0.52) PNPCNOT7PARNSMN1; SMN2ALDH1A1
SCHEMBL7984663 0.81 CNOT7 (0.49) PNPCNOT7PARNSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049544-B9 PURINONE DERIVATIVES AS HM74A AGONISTS INCYTE CORP (US) 2011-07-20 EP disclosed
US-7902205-B2 Purinone derivatives as HM74A agonists INCYTE CORPORATION (US) 2011-03-08 US disclosed
US-7863285-B2 Purinone derivatives as HM74A agonists INCYTE CORPORATION (US) 2011-01-04 US disclosed
EP-2049544-B1 PURINONE DERIVATIVES AS HM74A AGONISTS INCYTE CORP (US) 2010-11-03 EP disclosed
EP-2049544-A2 PURINONE DERIVATIVES AS HM74A AGONISTS Incyte Corporation (US) 2009-04-22 EP disclosed
US-20090088446-A1 PURINONE DERIVATIVES AS HM74A AGONISTS INCYTE CORPORATION (US) 2009-04-02 US disclosed
US-20090076269-A1 PURINONE DERIVATIVES AS HM74A AGONISTS INCYTE CORPORATION (US) 2009-03-19 US disclosed
US-7462624-B2 Purinone derivatives as HM74a agonists INCYTE CORPORATION (US) 2008-12-09 US disclosed
US-20080045555-A1 PURINONE DERIVATIVES AS HM74A AGONISTS INCYTE CORPORATION (US) 2008-02-21 US disclosed
WO-2007150026-A2 PURINONE DERIVATIVES AS HM74A AGONISTS INCYTE CORPORATION (US) 2007-12-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090088446-A1 PURINONE DERIVATIVES AS HM74A AGONISTS GPR84, P2RY1, ADRA1A PNP 1193/4885CNOT7 3149/4885PARN 2151/4885
US-20090076269-A1 PURINONE DERIVATIVES AS HM74A AGONISTS GPR84, P2RY1, ADRA1A PNP 1193/4885CNOT7 3149/4885PARN 2151/4885
US-20080045555-A1 PURINONE DERIVATIVES AS HM74A AGONISTS GPR84, P2RY1, ADRA1A PNP 1193/4885CNOT7 3149/4885PARN 2151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.